{"id":"F2022L01398","name":"Statement of Principles concerning restless legs syndrome (Reasonable Hypothesis) (No. 113 of 2022)","slug":"statement-of-principles-concerning-restless-legs-syndrome-reasonable-hypothesis-no-113-of-2022","collection":"legislative_instrument","jurisdiction":"commonwealth","status":"in_force","isInForce":true,"actNumber":null,"makingDate":null,"administeringDepartment":null,"currentVersion":{"id":441585,"registerId":"F2022L01398-fast-fetch-1775956847229","compilationNumber":null,"startDate":"2026-04-12","status":"InForce","reasons":null,"registeredAt":null},"sections":[{"sectionNumber":"1","sectionType":"section","heading":"Statement of Principles concerning restless legs syndrome (Reasonable Hypothesis) (No. 113 of 2022)","content":"---\nmeta-content-style-type: text/css\nmeta-content-type: application/xhtml+xml; charset=utf-8\nmeta-generator: Aspose.Words for .NET 22.10.0\n---\n\n?xml version=\"1.0\" encoding=\"utf-8\" standalone=\"no\"?>\n\n\n\n \n\nStatement of Principles\n\nconcerning\n\nRESTLESS LEGS SYNDROME (Reasonable Hypothesis)\n\n(No. 113 of 2022)\n\nThe Repatriation Medical Authority determines the following Statement of Principles under subsection 196B(2) of the Veterans' Entitlements Act 1986.\n\n \n\nDated 21 October 2022.\n\n \n\n \n\n \n\n \n\n \n\n| The Common Seal of the Repatriation Medical Authority was affixed to this instrument at the direction of:
|\n| --- |\n|
Professor Terence Campbell AM
Chairperson
|\n\n\n \n\n \n\n\nContents\n\n1 Name\n\n2 Commencement\n\n3 Authority\n\n4 Repeal\n\n5 Application\n\n6 Definitions\n\n7 Kind of injury, disease or death to which this Statement of Principles relates\n\n8 Basis for determining the factors\n\n9 Factors that must exist\n\n10 Relationship to service\n\n11 Factors referring to an injury or disease covered by another Statement of Principles\n\nSchedule 1 - Dictionary\n\n1 Definitions\n\n \n\n\n\n\n1 Name\n\nThis is the Statement of Principles concerning restless legs syndrome (Reasonable Hypothesis) (No. 113 of 2022).\n\n2 Commencement\n\n This instrument commences on 21 November 2022.\n\n3 Authority\n\nThis instrument is made under subsection 196B(2) of the Veterans' Entitlements Act 1986.\n\n4 Repeal\n\nThe Statement of Principles concerning restless legs syndrome No. 20 of 2014 (Federal Register of Legislation No. F2014L00307) made under subsections 196B(2) and (8) of the VEA is repealed.\n\n5 Application\n\nThis instrument applies to a claim to which section 120A of the VEA or section 338 of the Military Rehabilitation and Compensation Act 2004 applies.\n\n6 Definitions\n\nThe terms defined in the Schedule 1 - Dictionary have the meaning given when used in this instrument.\n\n7 Kind of injury, disease or death to which this Statement of Principles relates\n\n(1) This Statement of Principles is about restless legs syndrome and death from restless legs syndrome.\n\nMeaning of restless legs syndrome\n\n(2) For the purposes of this Statement of Principles, restless legs syndrome:\n\n(a) means a sensorimotor neurological disorder, in which there is:\n\n(i) a strong urge to move the legs, usually accompanied or caused by uncomfortable and unpleasant sensations in the legs; and\n\n(ii) the urge to move or unpleasant sensations begin or worsen during periods of rest or inactivity such as lying or sitting; and\n\n(iii) the urge to move or unpleasant sensations are partially or totally relieved by movement, such as walking or stretching; and\n\n(iv) the urge to move or unpleasant sensations are worse in the evening or night than during the day, or only occur in the evening or night; and\n\n(b) these clinical features:\n\n(i) occur at least 3 times per week, and have persisted for at least 3 consecutive months; and\n\n(ii) cause significant distress, or impairment in behavioural, social, physical or occupational functioning; and\n\n(iii) are not solely accounted for by another medical or behavioural condition.\n\nNote: Examples of other medical or behavioural conditions with clinical features that mimic restless legs syndrome include myalgia, venous stasis, leg oedema, arthritis, leg cramps and habitual foot tapping.\n\n(3) While restless legs syndrome attracts ICD‑10‑AM code G25.81, in applying this Statement of Principles the meaning of restless legs syndrome is that given in subsection (2).\n\n(4) For subsection (3), a reference to an ICD-10-AM code is a reference to the code assigned to a particular kind of injury or disease in The International Statistical Classification of Diseases and Related Health Problems, Tenth Revision, Australian Modification (ICD-10-AM), Tenth Edition, effective date of 1 July 2017, copyrighted by the Independent Hospital Pricing Authority, ISBN 978-1-76007-296-4.\n\nDeath from restless legs syndrome\n\n(5) For the purposes of this Statement of Principles, restless legs syndrome, in relation to a person, includes death from a terminal event or condition that was contributed to by the person's restless legs syndrome.\n\nNote: terminal event is defined in the Schedule 1 – Dictionary.\n\n8 Basis for determining the factors\n\nThe Repatriation Medical Authority is of the view that there is sound medical‑scientific evidence that indicates that restless legs syndrome and death from restless legs syndrome can be related to relevant service rendered by veterans, members of Peacekeeping Forces, or members of the Forces under the VEA, or members under the MRCA.\n\nNote: MRCA, relevant service and VEA are defined in the Schedule 1 – Dictionary.\n\n9 Factors that must exist\n\nAt least one of the following factors must as a minimum exist before it can be said that a reasonable hypothesis has been raised connecting restless legs syndrome or death from restless legs syndrome with the circumstances of a person's relevant service:\n\n(1) having diabetes mellitus at the time of the clinical onset of restless legs syndrome;\n\n(2) having iron deficiency at the time of the clinical onset of restless legs syndrome;\n\nNote: iron deficiency is defined in the Schedule 1 – Dictionary.\n\n(3) having chronic renal failure at the time of the clinical onset of restless legs syndrome;\n\nNote: chronic renal failure is defined in the Schedule 1 - Dictionary.\n\n(4) having a neurological disorder from the specified list of neurological disorders, involving the lower limbs, at the time of the clinical onset of restless legs syndrome;\n\nNote: specified list of neurological disorders is defined in the Schedule 1 – Dictionary.\n\n(5) having Parkinson's disease at the time of the clinical onset of restless legs syndrome;\n\n(6) taking a drug from the specified list of drugs:\n\n(a) as prescribed for ongoing use; and\n\n(b) within the 30 days before the clinical onset of restless legs syndrome;\n\nNote: specified list of drugs is defined in the Schedule 1 - Dictionary.\n\n(7) having multiple sclerosis at the time of the clinical onset of restless legs syndrome;\n\n(8) having a clinically significant disorder of mental health as specified at the time of the clinical onset of restless legs syndrome;\n\nNote: clinically significant disorder of mental health as specified is defined in the Schedule 1 - Dictionary. \n\n(9) receiving spinal anaesthesia within the 30 days before the clinical onset of restless legs syndrome;\n\n(10) having smoked tobacco products in an amount of at least 5 pack-years before the clinical onset of restless legs syndrome, and if smoking has ceased before the clinical onset of restless legs syndrome, then that onset occurred within 5 years of cessation;\n\nNote: one pack-year is defined in the Schedule 1 - Dictionary.\n\n(11) being obese for at least the 5 years before the clinical onset of restless legs syndrome;\n\nNote: being obese is defined in the Schedule 1 – Dictionary.\n\n(12) having narcolepsy or obstructive sleep apnoea at the time of the clinical onset of restless legs syndrome;\n\n(13) being pregnant at the time of the clinical onset of restless legs syndrome;\n\n(14) inability to undertake physical activity greater than 3 METs for a continuous period of at least the 1 year before the clinical onset of restless legs syndrome;\n\nNote: MET is defined in the Schedule 1 – Dictionary.\n\n(15) having dyslipidaemia for at least the 1 year before the clinical onset of restless legs syndrome;\n\nNote: dyslipidaemia is defined in the Schedule 1 – Dictionary.\n\n(16) having migraine at the time of the clinical onset of restless legs syndrome;\n\n(17) having chronic obstructive pulmonary disease or asthma at the time of the clinical onset of restless legs syndrome;\n\n(18) having a cerebrovascular accident within 3 months before the clinical onset of restless legs syndrome;\n\n(19) having diabetes mellitus at the time of the clinical worsening of restless legs syndrome;\n\n(20) having iron deficiency at the time of the clinical worsening of restless legs syndrome;\n\nNote: iron deficiency is defined in the Schedule 1 – Dictionary.\n\n(21) having chronic renal failure at the time of the clinical worsening of restless legs syndrome;\n\nNote: chronic renal failure is defined in the Schedule 1 - Dictionary.\n\n(22) having a neurological disorder from the specified list of neurological disorders, involving the lower limbs, at the time of the clinical worsening of restless legs syndrome;\n\nNote: specified list of neurological disorders is defined in the Schedule 1 – Dictionary.\n\n(23) having Parkinson's disease at the time of the clinical worsening of restless legs syndrome;\n\n(24) taking a drug from the specified list of drugs:\n\n(a) as prescribed for ongoing use; and\n\n(b) within the 30 days before the clinical worsening of restless legs syndrome;\n\nNote: specified list of drugs is defined in the Schedule 1 – Dictionary.\n\n(25) having multiple sclerosis at the time of the clinical worsening of restless legs syndrome;\n\n(26) having a clinically significant disorder of mental health as specified at the time of the clinical worsening of restless legs syndrome;\n\nNote: clinically significant disorder of mental health as specified is defined in the Schedule 1 - Dictionary. \n\n(27) receiving spinal anaesthesia within the 30 days before the clinical worsening of restless legs syndrome;\n\n(28) having smoked tobacco products in an amount of at least 5 pack-years before the clinical worsening of restless legs syndrome, and if smoking has ceased before the clinical worsening of restless legs syndrome, then that worsening occurred within 5 years of cessation;\n\nNote: one pack-year is defined in the Schedule 1 - Dictionary.\n\n(29) being obese for at least the 5 years before the clinical worsening of restless legs syndrome;\n\nNote: being obese is defined in the Schedule 1 – Dictionary.\n\n(30) having narcolepsy or obstructive sleep apnoea at the time of the clinical worsening of restless legs syndrome;\n\n(31) being pregnant at the time of the clinical worsening of restless legs syndrome;\n\n(32) inability to undertake physical activity greater than 3 METs for a continuous period of at least the 1 year before the clinical worsening of restless legs syndrome;\n\nNote: MET is defined in the Schedule 1 – Dictionary.\n\n(33) having dyslipidaemia for at least the 1 year before the clinical worsening of restless legs syndrome;\n\nNote: dyslipidaemia is defined in the Schedule 1 – Dictionary.\n\n(34) having migraine at the time of the clinical worsening of restless legs syndrome;\n\n(35) having chronic obstructive pulmonary disease or asthma at the time of the clinical worsening of restless legs syndrome;\n\n(36) having a cerebrovascular accident within the 3 months before the clinical worsening of restless legs syndrome;\n\n(37) for restless legs syndrome augmentation only, taking a dopaminergic agent including levodopa and pramipexole, or tramadol, for a continuous period of at least the 3 months before that clinical worsening of restless legs syndrome;\n\nNote: restless legs syndrome augmentation is defined in the Schedule 1 – Dictionary.\n\n(38) inability to obtain appropriate clinical management for restless legs syndrome.\n\n10 Relationship to service\n\n(1) The existence in a person of any factor referred to in section 9, must be related to the relevant service rendered by the person.\n\n(2) The factors set out in subsections 9(19) to 9(38) apply only to material contribution to, or aggravation of, restless legs syndrome where the person's restless legs syndrome was suffered or contracted before or during (but did not arise out of) the person's relevant service.\n\n11 Factors referring to an injury or disease covered by another Statement of Principles\n\nIn this Statement of Principles:\n\n(1) if a factor referred to in section 9 applies in relation to a person; and\n\n(2) that factor refers to an injury or disease in respect of which a Statement of Principles has been determined under subsection 196B(2) of the VEA;\n\nthen the factors in that Statement of Principles apply in accordance with the terms of that Statement of Principles as in force from time to time.\n\n \n\n \n\nSchedule 1 - Dictionary \n\nNote: See Section 6\n\n1 Definitions\n\nIn this instrument:\n\n being obese means having a Body Mass Index (BMI) of 30 or greater.\n\nNote: BMI is also defined in the Schedule 1 - Dictionary.\n\n BMI means W/H2 where:\n\n(a) W is the person's weight in kilograms; and\n\n(b) H is the person's height in metres.\n\n chronic renal failure means:\n\n(a) having a glomerular filtration rate of less than 15 mL/min/1.73 m2 for a period of at least 3 months; or\n\n(b) a need for renal replacement therapy (dialysis or transplantation) for treatment of complications of decreased glomerular filtration rate which would otherwise increase the risk of morbidity and mortality; or\n\n(c) undergoing chronic dialysis.\n\n clinically significant disorder of mental health as specified means one of the following conditions, which is of sufficient severity to warrant ongoing management:\n\n(a) anxiety disorder;\n\n(b) attention deficit hyperactivity disorder; or\n\n(c) depressive disorder.\n\nNote 1: Management of the condition may involve regular visits (for example, at least monthly) to a psychiatrist, counsellor or general practitioner.\n\nNote 2: To warrant ongoing management does not require that any actual management was received or given for the condition.\n\n dyslipidaemia means persistently abnormal blood lipid levels, diagnosed by a medical practitioner and evidenced by:\n\n(a) a serum high density lipoprotein cholesterol level less than 1.0 mmol/L; or\n\n(b) a serum low density lipoprotein cholesterol level greater than 4.0 mmol/L; or\n\n(c) a serum triglyceride level greater than or equal to 2.0 mmol/L; or\n\n(d) a total serum cholesterol level greater than 5.5 mmol/L; or\n\n(e) the regular administration of drug therapy to normalise blood lipid levels.\n\n iron deficiency means having a serum ferritin level of less than 30 micrograms per litre.\n\n MET means a unit of measurement of the level of physical exertion. 1 MET = 3.5 ml of oxygen/kg of body weight per minute, or 1.0 kcal/kg of body weight per hour, or resting metabolic rate.\n\n MRCA means the Military Rehabilitation and Compensation Act 2004.\n\n one pack-year means the amount of tobacco consumed in smoking 20 cigarettes per day for a period of 1 year, or an equivalent amount of tobacco products.\n\nNote 1: An equivalent amount of tobacco products is 7,300 grams of smoking tobacco by weight, either in cigarettes, pipe tobacco or cigars, or a combination of same. For pipe tobacco, cigars or combinations of multiple tobacco types, 1 gram of tobacco is considered to be equal to one cigarette.\n\nNote 2: Pack-years are calculated by dividing the number of cigarettes smoked per day by 20 and multiplying this number by the number of years the person has smoked. For example, smoking 10 cigarettes per day for 10 years is equal to 5 pack-years, and smoking 40 cigarettes per day for 10 years is equal to 20 pack-years.\n\n radiculopathy means a disease of the nerve roots resulting in symptoms of weakness, pain or loss of sensation.\n\n relevant service means:\n\n(a) operational service under the VEA;\n\n(b) peacekeeping service under the VEA;\n\n(c) hazardous service under the VEA;\n\n(d) British nuclear test defence service under the VEA;\n\n(e) warlike service under the MRCA; or\n\n(f) non-warlike service under the MRCA.\n\nNote: MRCA and VEA are also defined in the Schedule 1 - Dictionary.\n\n restless legs syndrome—see subsection 7(2).\n\n restless legs syndrome augmentation means a worsening of restless legs symptoms caused by long-term high dose drug therapy for that disease.\n\nNote: Augmentation is characterised by more severe symptoms and earlier onset of symptoms during the day. It often involves the spread of symptoms to the arms or other regions of the body.\n\n specified list of drugs means:\n\n(a) antipsychotics including olanzapine and quetiapine;\n\n(b) enzalutamide;\n\n(c) histamine H2-receptor antagonists including chlorpheniramine and hydroxyzine;\n\n(d) lithium;\n\n(e) proton pump inhibitors;\n\n(f) selective serotonin re-uptake inhibitors including citalopram, escitalopram, fluoxetine and sertraline;\n\n(g) serotonin-norepinephrine reuptake inhibitors including venlafaxine;\n\n(h) tetracyclic antidepressants including mianserin and mirtazapine;\n\n(i) topiramate;\n\n(j) tricyclic antidepressants including amitriptyline; or\n\n(k) zonisamide.\n\n specified list of neurological disorders means:\n\n(a) a spinal cord lesion;\n\n(b) peripheral neuropathy; or\n\n(c) radiculopathy.\n\nNote 1: Examples of causes of spinal cord lesions include transverse myelitis, neoplasm, trauma, syringomyelia and compression of the spine.\n\nNote 2: radiculopathy is also defined in the Schedule 1 – Dictionary.\n\n terminal event means the proximate or ultimate cause of death and includes the following:\n\n(a) pneumonia;\n\n(b) respiratory failure;\n\n(c) cardiac arrest;\n\n(d) circulatory failure; or\n\n(e) cessation of brain function.\n\n VEA means the Veterans' Entitlements Act 1986.\n\n \n\n \n","sortOrder":0}],"analysis":{"kimi_summary":{"content_quality":"ok","complexity_score":5,"scope_assessment":{"changed":false,"description":"This instrument maintains the standard scope of Repatriation Medical Authority Statements of Principles. It replaces the 2014 version (No. 20 of 2014) with updated medical criteria but does not expand beyond the established purpose of determining service-relatedness for restless legs syndrome in the veterans' compensation scheme."},"complexity_factors":["38 distinct factors with specific temporal requirements (e.g., 'within 30 days', 'at least 5 years before', 'at least 3 months')","18 defined terms in Schedule 1, including nested definitions (e.g., 'being obese' defined via BMI, which is itself defined)","Dual structure covering both 'clinical onset' (factors 1-18) and 'clinical worsening' (factors 19-38), with factor 37 applying only to a specific subtype ('restless legs syndrome augmentation')","Cross-references to other Statements of Principles for conditions mentioned in the factors (section 11)","Specific medical thresholds requiring measurement (e.g., serum ferritin <30 µg/L, GFR <15 mL/min, BMI ≥30, METs >3)","Complex tobacco exposure calculation using 'pack-years' with cessation timing rules"],"plain_english_summary":"This Statement of Principles defines when restless legs syndrome (RLS) can be treated as service-related for veterans and current/former defence members claiming under the Veterans' Entitlements Act or MRCA. It sets medical criteria and names 38 factors that can create a \"reasonable hypothesis\" linking RLS to service, guiding the Repatriation Medical Authority’s decisions. It updates and replaces the 2014 version and is the legal gateway to compensation for RLS."},"flash_summary":{"complexity_score":5,"scope_assessment":{"changed":true,"description":"This instrument expressly repeals and replaces the 2014 Statement of Principles for restless legs syndrome (s4). Compared with a typical earlier SoP form, this version adds or clarifies multiple measurable thresholds and a broader set of listed factors (for example: explicit dyslipidaemia thresholds, a defined obesity/BMI cutoff, an explicit list of medications, a named augmentation provision and the factor \"inability to obtain appropriate clinical management\"). It also separates onset and worsening factors with different timing rules (section 9 and section 10(2)). Those additions and the move to more prescriptive numerical criteria indicate an expansion and refinement of scope beyond the earlier instrument’s textual approach (see Schedule 1 and sections 7–10)."},"complexity_factors":["Replaces previous Statement of Principles (repeal of No.20 of 2014) increasing potential divergence from earlier criteria (s4).","Large list of 38 separate factors in section 9 (onset and worsening mirrored, some duplicated).","Approximately 17–20 defined terms in Schedule 1 with nested sub-definitions and numeric thresholds (e.g. ferritin <30 µg/L; GFR <15 mL/min/1.73 m2; BMI ≥30; lipid thresholds).","Multiple timing windows and duration requirements (e.g. within 30 days, within 3 months, 5 years since smoking cessation, obesity for at least 5 years, drug use ≥3 months for augmentation).","Cross-references to other Statements of Principles when a factor is itself another disease (s11).","Specific enumerated \"specified lists\" (drugs and neurological disorders) requiring medical interpretation and matching of generic/brand names (Schedule 1).","Conditional applicability: subsections 9(19)–9(38) apply only to material contribution/aggravation where RLS pre-existed or was contracted before/during but did not arise out of service (s10(2)).","Overlap between clinical diagnosis criteria (s7) and ICD‑10‑AM coding note (s7(3)–(4) ) — instrument relies on its own clinical definition rather than code alone.","Numerical computations required for exposure metrics (pack-years, BMI, METs) that depend on historical data and may be imprecise in practice."],"plain_english_summary":"**What this instrument does (mechanically)**\n\n- Replaces the earlier 2014 Statement of Principles for restless legs syndrome (RLS) and sets the medical rules the Repatriation Medical Authority (RMA) uses when deciding whether RLS (or death contributed to by RLS) can be linked to a veteran’s \"relevant service\" for compensation purposes (see sections 3–5, 7 and 4). It commenced on 21 November 2022 (section 2).\n\n- Defines, in clinical terms, what counts as restless legs syndrome for the purposes of claims (section 7(2)). That definition includes symptom pattern, frequency (≥3 times per week for ≥3 months), functional impact and exclusion of other conditions.\n\n- Lists the specific medical, behavioural and treatment-related factors that, if present and related to a person’s relevant service, are treated as raising a \"reasonable hypothesis\" that RLS (or death from RLS) is connected to service (section 9). At least one listed factor must exist for the reasonable hypothesis test to be met.\n\n- Distinguishes factors relevant to the clinical onset of RLS and factors relevant to clinical worsening of pre-existing RLS (section 9, separate items for onset and worsening). Some factors apply to both onset and worsening; others are specific.\n\n- Requires the factor(s) relied upon to be related to the person’s relevant service (section 10(1)). Subsections 9(19)–9(38) (the worsening list) apply only where the person’s RLS was suffered or contracted before or during (but did not arise out of) relevant service — i.e. they address material contribution or aggravation, not primary causation arising out of service (section 10(2)).\n\n- Cross‑references other Statements of Principles where a listed factor is itself an injury or disease already covered by another Statement of Principles (section 11).\n\n- Provides a detailed Dictionary (Schedule 1) that fixes numeric and clinical thresholds for many terms used in the instrument — for example: iron deficiency = serum ferritin < 30 µg/L; chronic renal failure = GFR < 15 mL/min/1.73 m2 for ≥3 months or dialysis; obesity = BMI ≥ 30; pack‑years and how to compute them; specified lists of drugs and neurological disorders; what counts as a terminal event; etc.\n\n\n**Who this affects**\n\n- Primary: veterans, members of the Australian Defence Force, members of Peacekeeping Forces and their dependants making claims under the Veterans' Entitlements Act 1986 (VEA) or the Military Rehabilitation and Compensation Act 2004 (MRCA) (see section 5 and Schedule 1 definitions).\n\n- Decision-makers: the Department responsible for administering VEA/MRCA claims, medical officers and the RMA who apply these medical rules when assessing causation or aggravation in claims.\n\n- Treating clinicians: clinical records and test results are the primary evidence used to establish the named factors (see Schedule 1 definitions with numeric thresholds).\n\n\n**Why it matters (official claim and practical effect)**\n\n- Official claim: the RMA states there is \"sound medical‑scientific evidence\" that RLS and death from RLS can be related to relevant service, and this instrument sets out the grounds on which a reasonable hypothesis of service connection may be raised (section 8).\n\n- Practical effect: the instrument operationalises a low‑threshold legal test — the \"reasonable hypothesis\" — by identifying specific, measurable medical factors (e.g. diabetes, iron deficiency, chronic renal failure, certain drugs, obesity, smoking measured in pack‑years, pregnancy, sleep apnoea, etc.) that, if present and related to service, support a finding that RLS is related to service (section 9 and Schedule 1). That reduces uncertainty about what evidence claimants need to bring and what adjudicators should look for.\n\n\n**Testing the official rationale against costs, incentives and implementation risks**\n\n- Who pays: financial liability (if a claim is accepted) is borne through the veterans’ compensation system under the VEA/MRCA; those costs flow from accepted links between RLS and service established under these rules (see sections 3 and 5).\n\n- Who decides: the RMA sets the medical criteria (this instrument); the administering agency and medical assessors apply them against clinical records and test results when deciding claims (sections 3, 5, 7, 9, Schedule 1).\n\n- Evidence and compliance burden: the instrument relies on clinical measurements and records (lab thresholds such as ferritin < 30, GFR, BMI, lipid values, documented pack‑years, medication history, timing windows such as 30 days or 3 months). That creates a clear evidentiary checklist but also a documentation burden for claimants and clinicians (Schedule 1; section 9). Lack of lab results or incomplete records may disadvantage claimants.\n\n- Incentives and substitution effects: because a single listed factor suffices to raise a reasonable hypothesis (section 9), there is an incentive for claimants and treating clinicians to document any qualifying condition or exposure. This may increase claims where such comorbidities are common (for example diabetes, obesity, iron deficiency).\n\n- Bureaucratic discretion and cross‑reference complexity: the instrument delegates definitional precision to Schedule 1 (numerical thresholds) and to other Statements of Principles where relevant (section 11). Adjudicators must interpret timing and relation to service (section 10), which can create case‑by‑case discretion.\n\n- Trade‑offs and opportunity costs: the instrument favours clarity and administrability (clear thresholds, lists of drugs/disorders) over individualized causal analysis in every case. That reduces adjudication time for straightforward cases but may misclassify complex cases where the listed factor is present but not biologically or temporally relevant.\n\n- Implementation risk: specific timing windows (e.g. drug exposure within 30 days before onset/worsening, smoking cessation within 5 years, drug duration for augmentation ≥3 months) and numerical cutoffs require accurate clinical dating and lab evidence; missing or ambiguous records create disputes about whether the reasonable hypothesis is met (section 9; Schedule 1).\n\n\n**Key legal mechanics to watch when applying the instrument**\n\n- The diagnosis of RLS must meet the clinical criteria in section 7(2) (symptom pattern, frequency, duration and functional impact).\n- At least one factor from section 9 must be present and shown to be related to the person’s relevant service (sections 9 and 10).\n- For claims alleging worsening of pre‑existing RLS, use the 9(19)–9(38) list and apply the limitation in section 10(2) about the pre‑existing timing.\n- If a listed factor is itself a disease covered by another Statement of Principles, that other Statement governs how that factor is applied (section 11).\n\n"},"flash_summary_failed":{"failed":true,"reason":"A positive credit balance is required for all requests, including BYOK, so fallback providers remain available. Add credits at https://vercel.com/d?to=%2F%5Bteam%5D%2F%7E%2Fai%3Fmodal%3Dtop-up to continue.","source":"analysis-cron"}},"importantCases":[],"_links":{"self":"/api/acts/statement-of-principles-concerning-restless-legs-syndrome-reasonable-hypothesis-no-113-of-2022","history":"/api/acts/statement-of-principles-concerning-restless-legs-syndrome-reasonable-hypothesis-no-113-of-2022/history","analysis":"/api/acts/statement-of-principles-concerning-restless-legs-syndrome-reasonable-hypothesis-no-113-of-2022/analysis","conflicts":"/api/acts/statement-of-principles-concerning-restless-legs-syndrome-reasonable-hypothesis-no-113-of-2022/conflicts","importantCases":"/api/acts/statement-of-principles-concerning-restless-legs-syndrome-reasonable-hypothesis-no-113-of-2022/important-cases","documents":"/api/acts/statement-of-principles-concerning-restless-legs-syndrome-reasonable-hypothesis-no-113-of-2022/documents"}}